Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Reclassification Rates of Patients Eligible for Active Surveillance After the Addition of Magnetic Resonance Imaging-Ultrasound Fusion Biopsy: An Analysis of 7 Widely Used Eligibility Criteria.
Nahar B, Katims A, Barboza MP, Soodana Prakash N, Venkatramani V, Kava B, Satyanarayana R, Gonzalgo ML, Ritch CR, Parekh DJ, Punnen S. Nahar B, et al. Among authors: katims a. Urology. 2017 Dec;110:134-139. doi: 10.1016/j.urology.2017.08.016. Epub 2017 Aug 24. Urology. 2017. PMID: 28842208
Risk Factors for Intravesical Recurrence after Minimally Invasive Nephroureterectomy for Upper Tract Urothelial Cancer (ROBUUST Collaboration).
Katims AB, Say R, Derweesh I, Uzzo R, Minervini A, Wu Z, Abdollah F, Sundaram C, Ferro M, Rha K, Mottrie A, Rosiello G, Simone G, Eun DD, Reese A, Kidd LC, Porter J, Bhattu AS, Gonzalgo ML, Margulis V, Marcus J, Danno A, Meagher M, Tellini R, Mari A, Veccia A, Ghoreifi A, Autorino R, Djaladat H, Mehrazin R. Katims AB, et al. J Urol. 2021 Sep;206(3):568-576. doi: 10.1097/JU.0000000000001786. Epub 2021 Apr 21. J Urol. 2021. PMID: 33881931
Practice trends for perioperative intravesical chemotherapy in upper tract urothelial carcinoma: Low but increasing utilization during minimally invasive nephroureterectomy.
Kenigsberg AP, Carpinito G, Gold SA, Meng X, Ghoreifi A, Djaladat H, Minervini A, Jamil M, Abdollah F, Farrow JM, Sundaram C, Uzzo R, Ferro M, Meagher M, Derweesh I, Wu Z, Porter J, Katims A, Mehrazin R, Mottrie A, Simone G, Reese AC, Eun DD, Bhattu AS, Gonzalgo ML, Carbonara U, Autorino R, Margulis V. Kenigsberg AP, et al. Among authors: katims a. Urol Oncol. 2022 Oct;40(10):452.e17-452.e23. doi: 10.1016/j.urolonc.2022.06.006. Epub 2022 Aug 4. Urol Oncol. 2022. PMID: 35934609
Bladder Cancer Carcinogens: Opportunities for Risk Reduction.
Gaffney CD, Katims A, D'Souza N, Bjurlin MA, Matulewicz RS. Gaffney CD, et al. Among authors: katims a. Eur Urol Focus. 2023 Jul;9(4):575-578. doi: 10.1016/j.euf.2023.03.017. Epub 2023 Apr 5. Eur Urol Focus. 2023. PMID: 37028984 Free PMC article. Review.
26 results